Kate Ennis
Sheffield, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Ivacaftor-tezacaftor-elexacaftor, tezacaftor-ivacaftor and lumacaftor-ivacaftor for treating cystic fibrosis: a systematic review and economic evaluation.
Journal: Health technology assessment (Winchester, England)
Published: May 26, 2025
Prehospital early warning scores for adults with suspected sepsis: the PHEWS observational cohort and decision-analytic modelling study.
Journal: Health technology assessment (Winchester, England)
Published: March 29, 2024
A model-based economic analysis of the CFHealthHub intervention to support adherence to inhaled medications for people with cystic fibrosis in the UK.
Journal: International journal of technology assessment in health care
Published: January 17, 2023
Guidance on the use of complex systems models for economic evaluations of public health interventions.
Journal: Health economics
Published: August 15, 2022
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
Journal: Health technology assessment (Winchester, England)
Published: January 06, 2022
A systematic review of meta-analyses assessing the validity of tumour response endpoints as surrogates for progression-free or overall survival in cancer.
Journal: British journal of cancer
Published: February 26, 2020
Correction to: The Future of Precision Medicine: Potential Impacts for Health Technology Assessment.
Correction to: The Future of Precision Medicine: Potential Impacts for Health Technology Assessment.
Journal: PharmacoEconomics
Published: October 27, 2018
The Future of Precision Medicine: Potential Impacts for Health Technology Assessment.
Journal: PharmacoEconomics
Published: July 14, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026